This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Oncology  • Breast Cancer  • Statistics and Research Methods  • Genetics  • Genetic Counseling/ Testing/ Therapy  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Are Researchers Doing Enough to Get Out the Correct Message?

Dezheng Huo, MD, PhD; Olufunmilayo I. Olopade, MD

JAMA. 2007;298(24):2910-2911.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

More than 10 years after BRCA1 and BRCA2 were discovered as major breast cancer susceptibility genes, the medical community is just beginning to get a glimpse of how germline mutations in these genes might be distributed among racial/ethnic minority populations in the United States. While a growing body of evidence documents the benefits of preventive measures having minimal risk for women with identifiable BRCA1 and BRCA2 mutations, genetic testing services remain underutilized by minority women. In this issue of JAMA, John and colleagues¹ provide information regarding the prevalence of pathogenic BRCA1 mutations in a population-based study among 5 US racial/ethnic groups in Northern California. Prevalence was particularly high among young African Americans, a group that has long been recognized as having a disproportionate burden of aggressive young-onset breast cancer.

With more than 200 000 women estimated to be diagnosed with breast cancer . . . [Full Text of this Article]

Author Affiliation: Department of Medicine, University of Chicago, Chicago, Illinois.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Prevalence of Pathogenic BRCA1 Mutation Carriers in 5 US Racial/Ethnic Groups
Esther M. John, Alexander Miron, Gail Gong, Amanda I. Phipps, Anna Felberg, Frederick P. Li, Dee W. West, and Alice S. Whittemore
JAMA. 2007;298(24):2869-2876.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups
Haffty et al.
Ann Oncol 2009;20:1653-1659.
ABSTRACT | FULL TEXT  

Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States
Huo et al.
JCO 2009;27:1184-1190.
ABSTRACT | FULL TEXT